Trial NCT04006847

View at ClinicalTrials.gov 
Org. Study IDs: 17-085

Last trial update was posted on 2022-07-01

MeSH Interventions

Bosutinib Dasatinib Nilotinib Tyrosine Kinase Inhibitors

MeSH Conditions

Leukemia Leukemia, Myelogenous, Chronic, BCR-ABL Positive Leukemia, Myeloid

Other Conditions

Chronic Myeloid Leukemia, Chronic Phase

Stopping Reasons

Product complaint

Limitations And Caveats

Due to the product issues, the trials was halted.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID